The HPV testing and Pap test market is expanding as healthcare systems place greater emphasis on cervical cancer prevention, early diagnosis, and accessible screening. The market was valued at USD 3.6 billion in 2025 and is projected to grow from USD 3.8 billion in 2026 to USD 6.2 billion by 2033, registering a 7.2% CAGR from 2026 to 2033. Technological advancements in testing products, the...
The allergy diagnostics and therapeutics market is expanding as the prevalence of allergic conditions rises and demand grows for earlier diagnosis, advanced testing, and effective treatment options. The market was valued at USD 37.1 billion in 2025 and is projected to reach USD 40.2 billion in 2026 and USD 78.0 billion by 2033, registering a CAGR of 10.0% from 2026 to 2033. Increasing adoption...
The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek